Business

Rakesh Jhunjhunwala’s portfolio included a huge jump of 130 rupees in the stock of this pharma company, bumper earning opportunity.

Today, the market is seeing a boom after declining for three consecutive trading sessions. Especially the pharma sector is seeing a boom of more than 4 percent at this time. Lumpin is said to be behind this boom. According to the data available on the NSE at 2 pm, Lupine shares are seeing a gain of 12.80 percent. This stock is also included in the portfolio of India’s Warren Buffett Rakesh Jhunjhunwala. He has a 1.6 per cent stake in this company.

At this time Lupin’s stock was trading at a level of Rs 1190 with a gain of 132 rupees (+ 12.42%). This is its 52-week high. This is the highest level since May 2017. On monthly basis, since December 2020, this stock has shown positive growth every month. In November 2020, it was at the level of 890, which has now reached the level of 1190. The company’s market cap is 53670 crores. Today the biggest boom of a year has been recorded in Lupine.

Expected to go until 1270

According to the information available on the Money Control website, this stock has given a return of 12 per cent in a week, 15 per cent in a month, 11 per cent in 3 months, 43 per cent in a year. Promoters hold a 46.86 per cent stake in the company. According to a report published in Mint, Ravi Singhal of GCL Securities said that once again the forma sector has started attracting investors. Lupine may go up to 1270 levels in the next one or two months.

Positive growth continuously for seven weeks

Talking about the Nifty Pharma Index, it has been closing with positive growth for the last seven weeks. It has been steadily increasing for the last three months on a monthly basis. Axis and ICICI Bank have decided to bring healthcare ETFs due to the interest of investors towards this sector.

Jhunjhunwala holds 1.6 percent stake

Talking about veteran investor Rakesh Jhunjhunwala, he has a 1.6 per cent stake in this company. He has held a total of 72.45 lakh shares with a value of 825 crores. They had a 1.5 per cent stake in the company in the September 2020 quarter, which they increased to 1.6 per cent in December. There has been no change in the March quarter.

read this also, Do not make these 5 mistakes while withdrawing money from PF Account, the application may get rejected

read this also, Axis Bank is giving big earning opportunity till May 10, know full detail

(Note: In this article you are given information about the past performance and various aspects of the stock. The stock market is full of risk, so take appropriate decisions keeping in mind the advice and advice of experts before investing.)

The post Rakesh Jhunjhunwala’s stock of this pharma company included a huge jump of 130 rupees, bumper earning opportunity appeared first on TV9 Hindi.

Related Articles